What is the usage and dosage in the instructions for Avonib/Tosovo?
Ivosidenib is a selective IDH1 inhibitor that has received widespread attention in recent years in the treatment of acute myeloid leukemia (AML), cholangiocarcinoma, and myelodysplastic syndrome (MDS). In the drug instructions, its recommended usage and dosage are clearly pointed out to help clinicians formulate more reasonable treatment plans for patients.
According to the instructions, the standard dose of ivonib is oral administration500 mg once a day, which can be taken with or without food, making it more convenient to take the drug. However, special attention should be paid to avoid taking it at the same time as high-fat food, because high-fat food will significantly change the absorption and metabolism of the drug, which may lead to abnormal blood drug concentration, thus affecting the efficacy and safety. Compared with other complex chemotherapy regimens, the administration method of ivonib is relatively simple and is more conducive to long-term management.

During the medication process, the treatment time is not limited to a fixed period, but it is recommended to continue taking it until the disease progresses or the patient experiences unacceptable adverse reactions. Such a description emphasizes the characteristics of this drug as a targeted therapy, that is, maintaining disease control through long-term suppression of the pathological mechanisms driven by IDH1 mutations. At the same time, doctors will regularly evaluate the patient's condition and tolerance, and adjust the plan if necessary to ensure a balance between efficacy and safety.
It is crucial for patients to adhere to regular medication regimens. Since the mechanism of action of ivonib in the body relies on long-term and sustained inhibition of mutation pathways, if the dose is reduced or discontinued without authorization midway, the risk of disease rebound or drug resistance may increase.
In addition, as an oral small molecule targeted drug, the instructions for ivonib also emphasize the need to be alert to potential side effects. For example, some patients may experience fatigue, loss of appetite, or mild gastrointestinal discomfort. Most of these conditions can be alleviated by adjusting diet or supportive treatment. However, if serious adverse reactions occur, the need to suspend medication should be evaluated in a timely manner under the guidance of a doctor.
Reference: https://www.tibsovo.com/
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)